AUD 0.08
(5.41%)
Year | Eps | Eps Growth |
---|---|---|
2024 | 0.01 AUD | -75.1% |
2023 | 0.02 AUD | 99.2% |
2022 | 0.01 AUD | 223.76% |
2021 | -0.01 AUD | 76.46% |
2020 | -0.04 AUD | -89.82% |
2019 | -0.02 AUD | -1983.33% |
2018 | 0.00 AUD | 700.0% |
2017 | -0.00 AUD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q3 | 0.00 AUD | -96.55% |
2024 Q4 | 0.00 AUD | 0.0% |
2024 Q1 | 0.00 AUD | -73.64% |
2024 FY | - AUD | -75.1% |
2024 Q2 | 0.01 AUD | 100.0% |
2023 FY | - AUD | 99.2% |
2023 Q2 | 0.01 AUD | 107.46% |
2023 Q3 | 0.01 AUD | -61.15% |
2023 Q1 | 0.01 AUD | 39.58% |
2023 Q4 | 0.01 AUD | 103.7% |
2022 Q2 | 0.01 AUD | 112.5% |
2022 Q1 | 0.00 AUD | 125.16% |
2022 FY | - AUD | 223.76% |
2022 Q4 | 0.00 AUD | 108.7% |
2022 Q3 | 0.00 AUD | -72.94% |
2021 Q2 | -0.02 AUD | -4000.0% |
2021 FY | - AUD | 76.46% |
2021 Q4 | -0.02 AUD | -1323.08% |
2021 Q3 | 0.00 AUD | 108.33% |
2021 Q1 | 0.00 AUD | 102.47% |
2020 FY | - AUD | -89.82% |
2020 Q3 | -0.01 AUD | 76.18% |
2020 Q4 | -0.02 AUD | -100.0% |
2020 Q2 | -0.03 AUD | -100.0% |
2020 Q1 | -0.02 AUD | -25.0% |
2019 Q1 | -0.28 AUD | 0.0% |
2019 FY | - AUD | -1983.33% |
2019 Q2 | -0.28 AUD | 0.0% |
2019 Q4 | -0.01 AUD | 93.82% |
2019 Q3 | -0.22 AUD | 21.43% |
2018 FY | - AUD | 700.0% |
2017 FY | - AUD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Althea Group Holdings Limited | -0.09 AUD | 107.268% |
Cann Group Limited | -0.11 AUD | 105.636% |
ECS Botanics Holdings Ltd | 0.00 AUD | -287.5% |
Ecofibre Limited | -0.12 AUD | 105.167% |
Elixinol Wellness Limited | -0.01 AUD | 150.407% |
Hygrovest Limited | -0.00 AUD | 1133.333% |
IDT Australia Limited | -0.02 AUD | 140.0% |
Invion Limited | -0.00 AUD | 788.889% |
Little Green Pharma Ltd | -0.04 AUD | 116.848% |
Live Verdure Ltd | -0.11 AUD | 105.636% |
Medical Developments International Limited | -0.46 AUD | 101.348% |
Vita Life Sciences Limited | 0.17 AUD | 96.353% |